Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

ABOS

Acumen Pharmaceuticals Inc

Dec 11 • 04:00PM ET

2.18

Dollar change +0.01
Percentage change 0.46	%

Healthcare • Biotechnology • USA • NASD

Peers: BIIB AVXL SAVA PRTA NBIX AXSM AUPH QURE VYGR CORT

| Held by: VTI IWM VXF IWN VTWO IWC AVSC VTWV RSSL DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.37	Insider Own	25.05%	Shs Outstand	60.08M	Perf Week	-3.54%
Market Cap	130.97M	Forward P/E	-	EPS next Y	-1.86	Insider Trans	0.00%	Shs Float	45.03M	Perf Month	-32.30%
Income	-81.67M	PEG	-	EPS next Q	-0.49	Inst Own	64.39%	Short Float	3.08%	Perf Quarter	-11.02%
Sales	0.00M	P/S	-	EPS this Y	-46.30%	Inst Trans	0.31%	Short Ratio	6.65	Perf Half Y	-19.26%
Book/sh	3.62	P/B	0.60	EPS next Y	-17.59%	ROA	-29.52%	Short Interest	1.39M	Perf Year	-19.85%
Cash/sh	3.33	P/C	0.65	EPS next 5Y	-	ROE	-32.83%	52W Range	2.08 - 5.09	Perf YTD	-43.23%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-54.03%	ROI	-33.06%	52W High	-57.17%	Beta	-0.07
Dividend TTM	-	Quick Ratio	10.43	Sales past 5Y	-28.84%	Gross Margin	-	52W Low	4.81%	ATR (14)	0.17
Dividend Ex-Date	-	Current Ratio	10.43	EPS Y/Y TTM	-23.23%	Oper. Margin	-	RSI (14)	40.19	Volatility	6.08% 7.81%
Employees	52	Debt/Eq	0.14	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	12.00
Option/Short	Yes / Yes	LT Debt/Eq	0.14	EPS Q/Q	-107.37%	Payout	-	Rel Volume	2.11	Prev Close	2.17
Sales Surprise	-	EPS Surprise	-38.24%	Sales Q/Q	-	Earnings	Nov 12 BMO	Avg Volume	208.39K	Price	2.18
SMA20	-5.38%	SMA50	-14.48%	SMA200	-26.98%	Trades		Volume	429,791	Change	0.46%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Initiated	Citigroup	Buy	$7
Dec-12-23	Initiated	Deutsche Bank	Buy	$8
Jul-20-23	Resumed	BofA Securities	Buy	$9 → $14
May-18-23	Initiated	Cantor Fitzgerald	Overweight	$13
Jul-15-22	Initiated	BTIG Research	Buy	$15
Jun-30-22	Initiated	H.C. Wainwright	Buy	$15
Jan-21-22	Upgrade	BofA Securities	Neutral → Buy	$16 → $14
Jul-26-21	Initiated	UBS	Buy	$27
Jul-26-21	Initiated	Stifel	Buy	$27
Jul-26-21	Initiated	Credit Suisse	Outperform	$26
Jul-26-21	Initiated	BofA Securities	Neutral	$20

Show Previous Ratings

Nov-26-24 04:00PM	Acumen Pharmaceuticals to Participate in the 7th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) -6.78%
Nov-13-24 02:06AM	Acumen Pharmaceuticals Inc (ABOS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ... (GuruFocus.com) -5.42%
Nov-12-24 10:54PM	Q3 2024 Acumen Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -16.93%
07:00AM	Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Nov-11-24 04:00PM	Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference (GlobeNewswire)
04:00PM	Loading…
Nov-06-24 04:00PM	Acumen Pharmaceuticals to Participate in the UBS Global Healthcare Conference (GlobeNewswire) +7.67%
08:00AM	Acumen Pharmaceuticals Appoints Dr. Amy Schacterle as Chief Regulatory Officer & Head of Quality (GlobeNewswire)
Nov-05-24 04:00PM	Acumen Pharmaceuticals to Report Third Quarter Results on Nov. 12, 2024 (GlobeNewswire)
Oct-31-24 08:05AM	Acumen Pharmaceuticals Presents Innovative Trial Screening Advancements Utilizing pTau217 Assay in Phase 2 Study of Sabirnetug for Early Alzheimer's Disease at the 17th Annual Clinical Trials on Alzheimer's Disease Conference (GlobeNewswire)
Oct-23-24 08:00AM	Acumen Pharmaceuticals to Deliver Late-Breaking Presentation at 17th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference (GlobeNewswire)
Sep-30-24 04:00PM	Acumen Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference (GlobeNewswire)
Sep-27-24 07:46AM	Acumen Pharmaceuticals extends collaboration with Lonza for sabirnetug (Pharmaceutical Business Review)
Sep-26-24 08:00AM	Acumen Pharmaceuticals Extends Collaboration with Lonza to Add Drug Product Manufacturing of Sabirnetug for Early Alzheimer's Disease (GlobeNewswire)
Sep-25-24 04:00PM	Acumen Pharmaceuticals to Host Virtual R&D Day on Oct. 2, 2024 (GlobeNewswire)
Sep-03-24 04:00PM	Acumen Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investor Conference (GlobeNewswire) -10.58%
11:26PM	Loading…
Aug-13-24 11:26PM	Q2 2024 Acumen Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +8.20% -9.21%
07:00AM	Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
Aug-06-24 04:00PM	Acumen Pharmaceuticals to Report Second Quarter Results on August 13, 2024 (GlobeNewswire) -7.32%
Jul-29-24 07:00AM	Acumen Pharmaceuticals Announces First Subject Dosed in Phase 1 Study of Subcutaneous Sabirnetug (ACU193) for Early Alzheimer's Disease (GlobeNewswire) -5.46%
Jul-28-24 07:30AM	Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC ) 2024 (GlobeNewswire)
Jul-11-24 08:00AM	Acumen Pharmaceuticals to Present Patient Experience and Biomarker Insights from Phase 1 INTERCEPT-AD Study at the Alzheimer's Association International Conference (AAIC ) 2024 (GlobeNewswire) +14.41%
Jun-21-24 11:13AM	Is Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) the Best Halal Stock According to Hedge Funds? (Insider Monkey)
10:53AM	7 Best Halal Stocks To Buy Now (Debt Free) (Insider Monkey)
May-15-24 03:00AM	Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ... (GuruFocus.com)
02:06AM	Q1 2024 Acumen Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
May-14-24 11:53AM	ABOS Stock Earnings: Acumen Pharmaceuticals Beats EPS for Q1 2024 (InvestorPlace) +9.82%
07:00AM	Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights (GlobeNewswire)
May-13-24 04:00PM	Acumen Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference (GlobeNewswire)
10:15AM	Arthur J. Gallagher Acquires Acumen Advisors (MT Newswires)
May-08-24 05:47PM	Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference (GlobeNewswire)
03:32PM	Loading…
03:32PM	Acumen Pharmaceuticals Doses 1st Patient in Alzheimer's Disease Drug Study (MT Newswires)
08:00AM	Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer's Disease (GlobeNewswire)
May-07-24 04:00PM	Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024 (GlobeNewswire) -5.62%
Apr-19-24 12:13PM	12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By (Insider Monkey)
Apr-16-24 08:00AM	Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting (GlobeNewswire)
Apr-08-24 05:38PM	13 Best Penny Stocks to Buy According to Billionaire Ken Griffin (Insider Monkey)
Apr-04-24 02:12PM	Acumen Pharmaceuticals Collaborates with Lonza For Alzheimers Treatment (Exec Edge)
08:00AM	Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer's Disease (GlobeNewswire)
Apr-03-24 08:38AM	Why Acumen Pharmaceuticals (ABOS) Stock Might be a Great Pick (Zacks)
Mar-28-24 12:00PM	Acumen Pharmaceuticals (ABOS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-27-24 09:46AM	Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.33%
Mar-26-24 09:20PM	Q4 2023 Acumen Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -11.76%
11:52AM	ABOS Stock Earnings: Acumen Pharmaceuticals Misses EPS for Q4 2023 (InvestorPlace)
07:00AM	Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights (GlobeNewswire)
Mar-21-24 10:41AM	Is Acumen Pharmaceuticals (ABOS) Outperforming Other Medical Stocks This Year? (Zacks)
08:00AM	Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting (GlobeNewswire)
Mar-19-24 04:00PM	Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024 (GlobeNewswire)
Mar-18-24 10:31AM	15 Best Anti-Aging Foods for Youthful Skin (Insider Monkey)
Mar-12-24 04:00PM	Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days (GlobeNewswire) +5.58%
Mar-08-24 08:50AM	Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD 2024 Annual Meeting (GlobeNewswire)
Feb-29-24 09:40AM	Has Acumen Pharmaceuticals (ABOS) Outpaced Other Medical Stocks This Year? (Zacks)
Feb-21-24 08:00AM	Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer's at the AD/PD 2024 Annual Meeting (GlobeNewswire)
Feb-01-24 07:00AM	Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer (GlobeNewswire)
Jan-30-24 02:14PM	Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot (InvestorPlace)
Jan-24-24 01:58PM	3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom (InvestorPlace)
Jan-04-24 04:15PM	Acumen Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-14-23 08:53AM	Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-13-23 11:08PM	Q3 2023 Acumen Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +6.84%
10:54AM	Acumen Pharmaceuticals Inc (ABOS) Reports Q3 2023 Financial Results and Provides Business Update (GuruFocus.com)
09:31AM	Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals? (PR Newswire)
07:00AM	Acumen Pharmaceuticals Secures $50.0 Million Credit Facility with K2 HealthVentures (GlobeNewswire)
07:00AM	Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
Nov-07-23 04:01PM	Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference (GlobeNewswire)
11:22AM	Q3 2023 Halozyme Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 04:01PM	Acumen Pharmaceuticals to Report Third Quarter Financial Results on November 13, 2023 (GlobeNewswire) -5.02%
07:30AM	Acumen Pharmaceuticals, Inc. and Halozyme Enter Global Collaboration and License Agreement to Develop Subcutaneous Formulation of ACU193 with ENHANZE Technology (GlobeNewswire)
Nov-02-23 04:00PM	Acumen Pharmaceuticals to Participate in the UBS Biopharma Conference (GlobeNewswire) +11.73%
Oct-27-23 09:25AM	Acumen Pharmaceuticals Presents Late-Breaker Phase 1 Updates Exploring Novel Target Engagement, Dosing Regimen and Safety Findings for ACU193 in Early Alzheimer's Disease at the 16th Annual Clinical Trials on Alzheimer's Disease (GlobeNewswire) -24.84%
Oct-04-23 08:00AM	Acumen Pharmaceuticals to Present Deeper Insights from First-in-Human Phase 1 Study of ACU193 for Early Alzheimer's During Symposium at the 16th Annual Clinical Trials on Alzheimer's Disease (CTAD) (GlobeNewswire)
Sep-19-23 04:00PM	Acumen Pharmaceuticals to Participate in the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 04:00PM	Acumen Pharmaceuticals to Participate in the H.C. Wainwright Annual Global Investment Conference (GlobeNewswire) -5.40%
Aug-08-23 10:21PM	Q2 2023 Acumen Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire)
Aug-01-23 04:00PM	Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 8, 2023 (GlobeNewswire)
Jul-25-23 01:47PM	Acumen Pharmaceuticals (NASDAQ:ABOS) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Jul-18-23 10:31PM	Acumen Announces Pricing of Upsized $130 Million Public Offering (GlobeNewswire) -17.70% -7.38%
11:32AM	Why Shares of Acumen Pharmaceuticals Are Down Tuesday (Motley Fool)
Jul-17-23 04:53PM	Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock (GlobeNewswire) +54.78%
07:00AM	Acumen Pharmaceuticals to Hold Conference Call to Discuss Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimers Disease (GlobeNewswire)
Jul-16-23 03:00AM	Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimers Disease at the Alzheimers Association International Conference (AAIC) 2023 (GlobeNewswire)
02:00AM	Acumen's Alzheimer's drug passes initial safety test (Reuters)
Jul-03-23 05:13PM	12 Best NASDAQ Penny Stocks to Buy (Insider Monkey) +5.04%
Jun-28-23 06:30AM	Kineta Expands Board of Directors with Biotech Industry Leaders Kim Drapkin and Scott Dylla (GlobeNewswire)
Jun-13-23 07:00AM	Acumen Pharmaceuticals to Present Topline Results from First-in-Human Phase 1 Study of ACU193 for Early Alzheimers Disease During Featured Research Session at the Alzheimers Association International Conference (AAIC®) 2023 (GlobeNewswire) +13.49%
May-16-23 12:41PM	Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q1 2023 Earnings Call Transcript (Insider Monkey) -9.52%
May-09-23 07:00AM	Acumen Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Highlights (GlobeNewswire) +18.14%
May-04-23 04:01PM	Acumen Pharmaceuticals to Participate in 2023 Bank of America Healthcare Conference (GlobeNewswire) +30.62%
May-02-23 04:01PM	Acumen Pharmaceuticals to Report First Quarter Financial Results on May 9, 2023 (GlobeNewswire) -6.09% +7.57%
Apr-09-23 08:57AM	Institutions own 26% of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares but private equity firms control 42% of the company (Simply Wall St.)
Mar-29-23 07:30AM	Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-28-23 08:00AM	Acumen Pharmaceuticals Presents in vitro Human Neuron Model for Evaluating Binding of Amyloid Beta Oligomers in Alzheimers Disease (GlobeNewswire)
Mar-27-23 07:00AM	Acumen Pharmaceuticals Reports Financial Results for Full Year Ended December 31, 2022 and Business Highlights (GlobeNewswire) +7.40%
Mar-22-23 04:01PM	Acumen Pharmaceuticals to Participate in Stifel 2023 Virtual CNS Days (GlobeNewswire) +5.15%
Mar-20-23 04:01PM	Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2022 Financial Results on March 27, 2023 (GlobeNewswire)
Mar-08-23 04:01PM	Acumen Pharmaceuticals to Participate in the Needham Neuroscience Forum (GlobeNewswire)
Feb-15-23 12:07PM	Acumen Pharmaceuticals (NASDAQ:ABOS) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Feb-13-23 08:00AM	Acumen Pharmaceuticals Completes Enrollment in Phase 1 Trial of ACU193, First Monoclonal Antibody Developed to Selectively Target Toxic A Oligomers in Patients with Early Alzheimers Disease (GlobeNewswire)
Jan-06-23 09:40AM	Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year? (Zacks) -8.55%
Jan-04-23 08:00AM	Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors (GlobeNewswire)
Dec-29-22 06:02AM	Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2022 Earnings Call Transcript (Insider Monkey) +11.64%

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Charlottesville, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
OConnell Daniel Joseph	President and CEO	Jan 19 '24	Sale	3.47	15,200	52,753	502,485	Jan 19 07:07 PM
Meisner Derek M	Chief Legal Officer & Corp Sec	Jan 19 '24	Sale	3.48	8,933	31,048	108,867	Jan 19 07:06 PM
Zuga Matt	CFO & Chief Business Officer	Jan 18 '24	Sale	3.71	4,242	15,717	211,445	Jan 19 07:05 PM
Siemers Eric	Chief Medical Officer	Jan 18 '24	Sale	3.71	3,124	11,604	117,576	Jan 19 07:05 PM
Barton Russell	Chief Operating Officer	Jan 18 '24	Sale	3.73	2,833	10,555	96,867	Jan 19 07:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABOS

Acumen Pharmaceuticals Inc

Upgrade your FINVIZ experience